SCHEMBL7947324

SCHEMBL7947324

COc1ccc(CC2CCN(Cc3cc(OC)c(OC)c(OC)c3)C2=O)cc1OC

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
CYP3A4 P08684 1/20 0.48
MAPT P10636 1/20 0.48
LMNA P02545 2/20 0.47
KDM4E B2RXH2 2/20 0.46
SIGMAR1 Q99720 1/20 0.46
ACHE P22303 2/20 0.45
CA1 P00915 4/20 0.44
CA2 P00918 4/20 0.44
CA9 Q16790 4/20 0.44
CA12 O43570 2/20 0.44
POLB P06746 1/20 0.44
MAPK1 P28482 1/20 0.44
ALDH1A1 P00352 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6992897 0.90 ALDH1A1 (0.47) MEN1KMT2ASMN1; SMN2MAPTLMNA
SCHEMBL7001262 0.89 MEN1 (0.57) MEN1KMT2AKDM4ESIGMAR1ACHE
SCHEMBL7961148 0.89 MEN1 (0.46) MEN1KMT2ASMN1; SMN2LMNAKDM4E
SCHEMBL6996711 0.87 ACHE (0.46) MEN1KMT2ASMN1; SMN2LMNAKDM4E
SCHEMBL7985035 0.85 ACHE (0.46) MEN1KMT2AKDM4ESIGMAR1ACHE
SCHEMBL7956635 0.82 KDM4E (0.42) MEN1KMT2ASMN1; SMN2LMNAKDM4E
SCHEMBL27406398 0.80 MEN1 (0.50) MEN1KMT2AMAPTKDM4ESIGMAR1
SCHEMBL27404097 0.78 ACHE (0.44) MEN1KMT2ASMN1; SMN2LMNAKDM4E
SCHEMBL16874556 0.77 SIGMAR1 (0.54) MEN1KMT2ASMN1; SMN2MAPTLMNA
SCHEMBL16874555 0.77 SIGMAR1 (0.54) MEN1KMT2ASMN1; SMN2MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6329392-B1 ANTIALLERGENS AVENTIS PHARMACEUTICALS, INC. 2001-12-11 US disclosed
EP-0777666-B1 SUBSTITUTED PIPERIDINES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES MERRELL PHARMA INC (US) 1999-03-03 EP disclosed
EP-0777666-A1 NOVEL SUBSTITUTED PIPERIDINES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES MERRELL PHARMACEUTICALS INC. (US) 1997-06-11 EP disclosed
WO-1996006094-A1 NOVEL SUBSTITUTED PIPERIDINES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES MERRELL PHARMACEUTICALS INC. (US) 1996-02-29 WO disclosed